• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EFSUMB 对动态对比增强超声(DCE-US)在肿瘤灌注量化中的应用介绍。

An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.

机构信息

Innere Medizin 2, Caritas-Krankenhaus, Bad Mergentheim.

出版信息

Ultraschall Med. 2012 Aug;33(4):344-51. doi: 10.1055/s-0032-1313026. Epub 2012 Jul 27.

DOI:10.1055/s-0032-1313026
PMID:22843433
Abstract

Dynamic Contrast Enhanced Ultrasound (DCE-US) is an imaging technique that utilizes microbubble contrast agents in diagnostic ultrasound. The EFSUMB guidelines published in 2004, updated in 2008 and 2011 focused on the use of DCE-US, including essential technical requirements, training, investigational procedures and steps, guidance on image interpretation, established and recommended clinical indications and safety considerations. However the quantification of images acquired with ultrasound contrast agents (UCAs) is not discussed in the guidelines. The purpose of this EFSUMB document is to provide some recommendations and descriptions of the quantification of ultrasound images, technical requirements for analysis of time-intensity curves (TICs), methodology for data analysis, and interpretation of the results.

摘要

动态对比增强超声(DCE-US)是一种利用诊断超声中的微泡对比剂的成像技术。2004 年发表的 EFSUMB 指南,分别于 2008 年和 2011 年进行了更新,重点关注 DCE-US 的应用,包括基本技术要求、培训、研究程序和步骤、图像解读指导、已确立和推荐的临床适应证以及安全性考虑。然而,这些指南中并未讨论超声对比剂(UCAs)获得的图像的定量。本文的目的是为超声图像的定量分析提供一些建议和描述,包括分析时间-强度曲线(TICs)的技术要求、数据分析方法以及结果解读。

相似文献

1
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.EFSUMB 对动态对比增强超声(DCE-US)在肿瘤灌注量化中的应用介绍。
Ultraschall Med. 2012 Aug;33(4):344-51. doi: 10.1055/s-0032-1313026. Epub 2012 Jul 27.
2
EFSUMB Technical Review - Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion.EFSUMB 技术评论-2023 更新:用于量化肿瘤灌注的动态对比增强超声(DCE-CEUS)。
Ultraschall Med. 2024 Feb;45(1):36-46. doi: 10.1055/a-2157-2587. Epub 2023 Sep 25.
3
EFSUMB guidelines 2011: comment on emergent indications and visions.EFSUMB 指南 2011:紧急适应证和愿景的评论。
Ultraschall Med. 2012 Jul;33 Suppl 1:S39-47. doi: 10.1055/s-0032-1312895. Epub 2012 Jun 21.
4
Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.动态对比增强超声(DCE-US)与动态对比增强计算机断层扫描(DCE-CT)相比,用于简便快速评估肝细胞癌——一项初步研究。
Ultraschall Med. 2012 Dec;33(6):587-92. doi: 10.1055/s-0032-1325545. Epub 2012 Nov 15.
5
Perfusion quantification in contrast-enhanced ultrasound (CEUS)--ready for research projects and routine clinical use.对比增强超声(CEUS)中的灌注定量——已准备好用于研究项目和常规临床应用。
Ultraschall Med. 2012 Jul;33 Suppl 1:S31-8. doi: 10.1055/s-0032-1312894. Epub 2012 Jun 21.
6
Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.超声造影定量分析肝内超声时间预测慢性乙型肝炎肝纤维化
Ultrasound Med Biol. 2010 Jul;36(7):1066-75. doi: 10.1016/j.ultrasmedbio.2010.04.012.
7
Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS).超声造影(CEUS)定量评估微血管血流。
Clin Hemorheol Microcirc. 2011;49(1-4):137-49. doi: 10.3233/CH-2011-1464.
8
Dynamic Vascular Pattern (DVP), a quantification tool for contrast enhanced ultrasound.动态血管模式(DVP),一种用于超声造影的量化工具。
Z Gastroenterol. 2013 May;51(5):427-31. doi: 10.1055/s-0032-1325371. Epub 2013 May 16.
9
Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.使用超声造影评估肝通过时间对肝脏局灶性病变的特征进行描述。
Radiology. 2010 Aug;256(2):648-55. doi: 10.1148/radiol.10090715.
10
[Quantification of tissue perfusion with novel ultrasound methods].[用新型超声方法定量组织灌注]
Radiologe. 2003 Oct;43(10):823-30. doi: 10.1007/s00117-003-0958-8.

引用本文的文献

1
How to Perform Cardiac Contrast-Enhanced Ultrasound (cCEUS): Part I.如何进行心脏对比增强超声检查(cCEUS):第一部分。
Diagnostics (Basel). 2025 Jul 9;15(14):1743. doi: 10.3390/diagnostics15141743.
2
Advanced ultrasound methods to improve chronic kidney disease diagnosis.用于改善慢性肾脏病诊断的先进超声方法。
Npj Imaging. 2024 Jul 25;2(1):22. doi: 10.1038/s44303-024-00023-5.
3
Role of elastography and dynamic contrast-enhanced ultrasound in the evaluation of pancreas transplantation rejection.弹性成像和动态对比增强超声在胰腺移植排斥反应评估中的作用。
Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11772-1.
4
Mapping of prostate cancer microvascular patterns using super-resolution ultrasound imaging.使用超分辨率超声成像绘制前列腺癌微血管模式
Eur Radiol Exp. 2025 Feb 20;9(1):25. doi: 10.1186/s41747-025-00561-6.
5
Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: a preliminary study by using contrast-enhanced ultrasound.重组人内皮抑素抗血管生成治疗可能改善鼻咽癌伴颈部淋巴结坏死患者的血流灌注:一项使用超声造影的初步研究
Front Oncol. 2025 Jan 31;15:1521762. doi: 10.3389/fonc.2025.1521762. eCollection 2025.
6
[Imaging in chronic inflammatory bowel disease].[慢性炎症性肠病的影像学检查]
Inn Med (Heidelb). 2025 Jan;66(1):40-54. doi: 10.1007/s00108-024-01831-y. Epub 2024 Dec 20.
7
Current trends in the characterization and monitoring of vascular response to cancer therapy.当前癌症治疗中血管反应的特征和监测趋势。
Cancer Imaging. 2024 Oct 23;24(1):143. doi: 10.1186/s40644-024-00767-8.
8
Dynamic contrast enhanced ultrasound in differential diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.动态对比增强超声在肝细胞癌鉴别诊断中的应用:一项系统评价和荟萃分析。
World J Gastrointest Oncol. 2024 Jun 15;16(6):2804-2815. doi: 10.4251/wjgo.v16.i6.2804.
9
The Role of Endoscopic Ultrasound and Ancillary Techniques in the Diagnosis of Autoimmune Pancreatitis: A Comprehensive Review.内镜超声及辅助技术在自身免疫性胰腺炎诊断中的作用:一项综述
Diagnostics (Basel). 2024 Jun 12;14(12):1233. doi: 10.3390/diagnostics14121233.
10
Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial.贝伐珠单抗为基础化疗治疗转移性结直肠癌患者肿瘤与肝脏密度比值的预后价值。STIC-AVASTIN 试验的事后研究。
Cancer Imaging. 2024 Jun 17;24(1):77. doi: 10.1186/s40644-024-00722-7.